Skip to main content
Article thumbnail
Location of Repository

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II

By Fereidoun Azizi, Arash Ghanbarian, Amir Abbas Momenan, Farzad Hadaegh, Parvin Mirmiran, Mehdi Hedayati, Yadollah Mehrabi and Saleh Zahedi-Asl
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). A motivational interviewing intervention to increase fruit and vegetable intake through black churches: results of the eat for life trial.
  2. (2005). A: Childhood obesity, prevalence and prevention.
  3. (2002). Ainy E, Moeini S: Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1). Soz Praventivmed
  4. (2006). Alberti KG: Chronic non-communicable diseases. Ann Trop Med Parasitol
  5. (1990). ALOD: ComputerAssisted data collection in Multicenter Epidemiologic Research: The Atherosclerosis Risk in Communities (ARIC) study. Controlled Clin Trials
  6. (1998). Amininik S: Prevalence of arterial hypertension in Busher port.
  7. (2002). An accelerated nutrition transition in Iran. Public Health Nutr
  8. (2007). Association: Nutrition Recommendations and Interventions for Diabetes A position statement of the American Diabetes Association. Diabetes Care
  9. (2006). Azizi F: Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care
  10. (2006). Azizi F: High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring)
  11. Azizi F: Prevalence of coronary heart disease among Tehranian adults: Tehran Lipid and Glucose Study. East Mediterr Health J
  12. (2005). Azizi F: Whole-grain consumption and the metabolic syndrome: a favorable association in Tehranian adults.
  13. (2003). Azizi T: Cardiovascular risk factors in the elderly: the Tehran Lipid and Glucose Study. J Cardiovasc Risk
  14. (1996). Blood Pressure Education Program Working Group on Hypertension Control
  15. (1998). CC: Evaluation and management of dyslipoproteinemia in children. Endocrinology and Metabolism Clinics of North America
  16. (2004). Centers For Disease Control And Prevention Primary Prevention Working Group: Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med
  17. (2006). Changing patient behavior. Endocr Pract
  18. (1974). Collaborative Group: An international controlled trail in the multifactorial prevention of coronary heart disease.
  19. (2001). Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bull World Health Organ
  20. (1988). Contributions of the Framingham Study to the conquest of coronary artery disease.
  21. (1977). DD: Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med
  22. (1995). DJ: Preventing non-insulindependent diabetes. Diabetes
  23. (1992). EJ: Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.
  24. (2001). Evaluation of implementation and effect of primary school based intervention to reduce risk factors for obesity. BMJ
  25. (2002). Guideline Update for the Management of Patients With Chronic Stable Angina A Report of the American College of Cardiology/American Heart Association Task Force
  26. (2002). Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force
  27. (1983). Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. Hypertension
  28. (2004). Is weight loss a realistic goal of treatment in type 2 diabetes? The implications of restraint theory. Patient Educ Couns
  29. (1999). Jr: Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA
  30. (1998). Jr: The antiatherogenic role of high-density lipoprotein cholesterol.
  31. (2002). KauferChristoffel K: a community based obesity prevention program for minority children. Prev Med
  32. (1999). Kianfar H: the manual for household measures, cooking yields factors and Edible portion of food. Tehran: keshavarzi press;
  33. (1997). Kuller LH: Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1999: 13:401–11. Reprined in: Modifiable Activity Questionnaire. Med J Sports Exerc
  34. (1993). Leon AS: Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc
  35. (1998). Low-density lipoproteins and risk for coronary artery disease.
  36. (2007). MJ: The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia
  37. (2006). New thinking about diet and cardiovascular disease.
  38. (2004). Nutrition for weight management. In Krause's food, nutrition and diet therapy 11th edition. Edited by: Mahan LK, Escottstump S. Saunders:
  39. (1998). Nutritional epidemiology 2nd edition.
  40. (1992). of Health and Human Services, Public Health Service: National Cholesterol Education Program: highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.
  41. (1985). Organization: Diabetes Mellitus: report of a WHO Study Group.
  42. (1998). Organization: Guideline for controlling and monitoring. The Tobacco Epidemic.
  43. (1995). Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine.
  44. (2007). physical activity, and cardiovascular disease: an update. Cardiovasc Res
  45. (1992). Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev
  46. (1998). Prionties in cardiovascular prevention
  47. (1992). Review of community intervention studies on cardiovascular risk factors. Clin Exp Hypertens A
  48. (1991). Rollnick S: Motivational interviewing: Preparing people to change addictive behaviors.
  49. (2006). Satku K: Changes in the levels of major cardiovascular risk factors in the multi-ethnic population in Singapore after 12 years of a national non-communicable disease intervention programme. Singapore Med J
  50. (2004). School-based obesity prevention in Chilean primary school children.
  51. (1999). Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. Acta Cardiol
  52. (1991). Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ
  53. (2001). Surveillance of risk factors for noncommunicable diseases: The WHO STEPwise approach. In Summary Geneva, World Health Organization;
  54. (2001). Surwit RS: Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care
  55. (2000). Tehran Lipid and Glucose Study: Rationale and Design. CVD prevention
  56. (1985). Ten years of the North Karelia project. Acta Med Scand Suppl
  57. (1982). The Minnesota code manual of electrocardiographic findings: standards and procedures for measurements and classification.
  58. (1974). The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study. G Ital Cardiol
  59. (1998). The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure [published erratum appears in Arch Intern Med
  60. (1997). Tokgozoglu SL: Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels.
  61. (1986). Tyroler HA: Highdensity lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation
  62. (2006). Volpe SL: School-based obesity prevention: Research, challenges, and recommendations.
  63. (1992). WC: Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.
  64. (2000). WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ
  65. (2004). WP: A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr
  66. (2003). Yousefie A: Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol
  67. (2003). Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract
  68. (1998). Zellipourl : Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease. East mediterr health

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.